<b>Background:</b> <i>ALK</i> and <i>ROS1</i> rearrangement accounts for 3-6% and 1-3% of non-small cell lung cancers, respectively, while coexistence of them in the same patient is extremely rare. The gene discussed is ALK; the disease is non-small cell lung carcinoma.